Coloplast Financial Statements From 2010 to 2024
| COLO-B Stock | DKK 891.60 18.40 2.11% |
Check Coloplast financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Coloplast's main balance sheet or income statement drivers, such as , as well as many indicators such as . Coloplast financial statements analysis is a perfect complement when working with Coloplast Valuation or Volatility modules.
Coloplast |
Coloplast AS Company Operating Margin Analysis
Coloplast's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Coloplast Operating Margin | 0.30 % |
Most of Coloplast's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Coloplast AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Coloplast AS has an Operating Margin of 0.2997%. This is 100.85% lower than that of the Healthcare sector and 106.39% lower than that of the Medical Instruments & Supplies industry. The operating margin for all Denmark stocks is 105.44% lower than that of the firm.
Coloplast AS Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Coloplast's current stock value. Our valuation model uses many indicators to compare Coloplast value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Coloplast competition to find correlations between indicators driving Coloplast's intrinsic value. More Info.Coloplast AS is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.23 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Coloplast AS is roughly 4.38 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Coloplast by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Coloplast's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Coloplast Financial Statements
Coloplast stakeholders use historical fundamental indicators, such as Coloplast's revenue or net income, to determine how well the company is positioned to perform in the future. Although Coloplast investors may analyze each financial statement separately, they are all interrelated. For example, changes in Coloplast's assets and liabilities are reflected in the revenues and expenses on Coloplast's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Coloplast AS. Please read more on our technical analysis and fundamental analysis pages.
Coloplast AS develops and markets intimate healthcare products and services worldwide. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast operates under Healthcare Products classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 12000 people.
Other Information on Investing in Coloplast Stock
Coloplast financial ratios help investors to determine whether Coloplast Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Coloplast with respect to the benefits of owning Coloplast security.